A password will be e-mailed to you.

More than 120 projects across Scotland will share £38 million to support survivors of gender-based violence and focus on prevention.

The Delivering Equally Safe Fund includes more than £28 million for frontline services which provide direct support to women and girls, prioritising services that maximise their safety and wellbeing.

The two-year fund has also been increased by an additional £1 million per year to support projects which focus on early intervention and preventative measures.

Funding will be distributed to 121 projects, including Respect, which provides helpline services for perpetrators of domestic abuse, Kingdom Abuse Survivors project and Moray Women’s Aid.

Equalities Minister Christina McKelvie said:

“Violence against women and girls is appalling and unacceptable which is why we are funding organisations that are tackling the issue head on, including frontline services that support survivors and get to the root of abusive behaviour.

These organisations are offering new and innovative ways to aid recovery, encourage education, and increase prevention awareness.

“I am also pleased that we have been able to increase our funding by more than £1 million a year more than our original fund to increase our support to these important initiatives.

“I look forward to seeing the  results of the important the work that Equally Safe Fund will deliver.”

Melanie Wood, from Moray Women’s Aid said:

“We are delighted to receive funding through the Delivering Equally Safe fund. It will allow us to continue to deliver essential services to vulnerable women, children and young people experiencing domestic abuse when they most needed it.

“The funding will support the work of our Community Outreach Project and the Children and Young Person’s Service.”

Source: Photo by Danie Franco on Unsplash 

Healthcare Professional ONLY
This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors